7-5900544-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_015622.6(CCZ1):āc.290A>Gā(p.Glu97Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,602,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., cov: 26)
Exomes š: 0.000031 ( 0 hom. )
Consequence
CCZ1
NM_015622.6 missense
NM_015622.6 missense
Scores
11
3
2
Clinical Significance
Conservation
PhyloP100: 8.76
Genes affected
CCZ1 (HGNC:21691): (CCZ1 homolog, vacuolar protein trafficking and biogenesis associated) Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in vesicle-mediated transport. Located in intracellular membrane-bounded organelle. Part of Mon1-Ccz1 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.817
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCZ1 | NM_015622.6 | c.290A>G | p.Glu97Gly | missense_variant | 3/15 | ENST00000325974.9 | NP_056437.4 | |
CCZ1 | XM_047420465.1 | c.290A>G | p.Glu97Gly | missense_variant | 3/11 | XP_047276421.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCZ1 | ENST00000325974.9 | c.290A>G | p.Glu97Gly | missense_variant | 3/15 | 1 | NM_015622.6 | ENSP00000325681 | P1 | |
CCZ1 | ENST00000628813.2 | c.218+163A>G | intron_variant | 2 | ENSP00000486988 | |||||
CCZ1 | ENST00000461592.1 | n.456A>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
CCZ1 | ENST00000478672.1 | n.309A>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 4AN: 149600Hom.: 0 Cov.: 26
GnomAD3 genomes
AF:
AC:
4
AN:
149600
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000234 AC: 4AN: 170868Hom.: 0 AF XY: 0.0000324 AC XY: 3AN XY: 92498
GnomAD3 exomes
AF:
AC:
4
AN:
170868
Hom.:
AF XY:
AC XY:
3
AN XY:
92498
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000310 AC: 45AN: 1452596Hom.: 0 Cov.: 32 AF XY: 0.0000332 AC XY: 24AN XY: 722370
GnomAD4 exome
AF:
AC:
45
AN:
1452596
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
722370
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000267 AC: 4AN: 149718Hom.: 0 Cov.: 26 AF XY: 0.0000274 AC XY: 2AN XY: 73064
GnomAD4 genome
AF:
AC:
4
AN:
149718
Hom.:
Cov.:
26
AF XY:
AC XY:
2
AN XY:
73064
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.290A>G (p.E97G) alteration is located in exon 3 (coding exon 3) of the CCZ1 gene. This alteration results from a A to G substitution at nucleotide position 290, causing the glutamic acid (E) at amino acid position 97 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Vest4
MutPred
Loss of disorder (P = 0.0701);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at